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This issue’s Select examines different molecular foundations of neurodegenerative disease. Loss of growth fac-
tors, impaired glutamate transport in glia, accumulation of damaged DNA, or defects in tRNA editing are some of
the complex mechanisms at work.
Mapping Mutations Reveals a New Player in Neurodegeneration
Frontotemporal dementia (FTD) has been linked to mutations in the gene on chromosome 17 that encodes the
microtubule-associated protein tau. However, not all patients with FTD have tau mutations even though their
disease has been genetically linked to chromosome 17. Such patients exhibit an unusual pathology with ubiquitin-
immunoreactive nuclear and cytoplasmic inclusions in layer II of the frontal and temporal neocortex. In companion
studies, Baker et al. (2006) and Cruts et al. (2006) set out to determine other genes on chromosome 17 that could
be responsible for FTD. Baker et al. (2006) sequenced the DNA of patients from one tau-negative FTD family that
showed linkage to chromosome 17 (FTDU-17). Cruts et al. (2006) analyzed the genes within a minimal candidate
region from a Dutch family and a Belgian family with FTDU-17. Both groups found mutations (frameshift and
nonsense) in the PRGN gene that encodes the growth factor progranulin. Additional analysis of PRGN sequences
from a number of other patients confirmed the prevalence in PRGN of frameshift and nonsense mutations that
would result in truncated gene products. The authors described several mechanisms through which mutations
could interfere with progranulin expression in the brains of FTDU-17 patients. These include nuclear retention
and degradation of unspliced PRGN transcripts due to a mutation in a splice donor site, lack of PRGN translation
due to a mutation in the translation initiation codon, and nonsense-mediated decay of mutant transcripts. More-
over, expression of truncated mutant progranulin could not be detected in brain tissue extracts or lymphoblasts of
patients. Interestingly, both studies found that progranulin does not seem to be part of the neuronal inclusions that
are seen in the neocortex of these patients. Taken together, both studies indicate that FTDU-17 is likely due to
PRGN loss of function and highlight the importance of progranulin for neuronal survival. Progranulin is important
in development, wound repair, inflammation, tumorigenesis, and activation of other growth factors like VEGF. It
will be interesting to elucidate the molecular details of how the loss of this growth factor leads to inclusions
and neurodegeneration and to determine the protein components of these inclusions.
M. Baker et al. (2006). Nature 442, 916–919. Published online July 16, 2006. 10.1038/nature05016.
M. Cruts et al. (2006). Nature 442, 920–924. Published online July 16, 2006. 10.1038/nature05017.
Getting Chewed up Can Be a Good Thing
A pathological feature of several neurodegenerative diseases including
Alzheimer’s disease is the presence of cytoplasmic neurofibrillary inclusions
that are comprised principally of tau, a microtubule-associated protein.
To identify proteins that protect against tau tangle-related neurodegenera-
tion, Karsten et al. (2006) used cross-species functional genomics. Using
microarrays, the authors analyzed gene expression in different regions of
the brains of transgenic mice expressing a human tau mutation that is
most frequently linked to the neurodegenerative disease frontotemporal
dementia. The authors focused on genes that are upregulated in the cerebel-
lum of the mutant mice as this brain region does not undergo tau-induced
degeneration. Interestingly, one of the upregulated genes, psa, had not been
implicated in conferring protection against neurodegeneration. Karsten
et al. (2006) also identified psa in a pilot genetic screen in a fly model of
tau-induced neurodegeneration (which manifests as a ‘‘rough eye’’ phenotype) to identify suppressors or enhancers
of this phenotype. The authors showed that PSA overexpression suppressed tau-induced neurodegeneration in the
eye whereas loss of PSA enhanced tau-induced neurodegeneration. Furthermore, they showed that PSA, which
encodes an aminopeptidase, digests tau in vitro. PSA is highly expressed in human cerebellum neurons compared
to those of the frontal cortex. Interestingly, the cerebellum is largely resistant to tau-induced neurodegeneration,
leading to speculation that PSA expression might prevent tau pathology in this part of the brain.
S.L. Karsten et al. (2006). Neuron 51, 549–560.
Glia Get in on the Act
Custer et al. (2006) examined the role that glia play in spinocerebellar ataxias (SCAs), a disease characterized by de-
generation of the cerebellum, brainstem, and spinal cord. There are a number of SCAs; SCA7 is caused by polyglut-
amine repeat expansions (polyQ) in the gene ataxin-7. Introduction of normal and polyQ expanded ataxin-7 into
mice resulted in Purkinje cell degeneration even though these neurons do not express the expanded Ataxin-7.
Ultrastructural analysis revealed that the observed abnormalities were reminiscent of Purkinje cell degeneration
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linked to excitotoxicity such as that caused by excess glutamate. Normally,
Bergmann glia (which surround and ensheath Purkinje neurons) remove
excess glutamate; however, these cells were swollen and dysfunctional
in mice that expressed expanded Ataxin-7. Examination of postmortem
cerebellar sections from three SCA7patients revealed similar defects in brain
glia. The authors specifically expressed the polyQ expanded ataxin-7 in
Bergmann glia (under control of a glial-specific promoter) in mice. Remark-
ably these mice showed Purkinje cell degeneration and consequent lack of
coordination characteristic of SCA, in addition to glia with swollen radial
processes. The mouse glial cells showed a reduction in expression of gluta-
mate receptors and reduced uptake of glutamate. The authors propose
that the impaired ability of glia to mop up excess glutamate may account
for the cerebellar neurodegeneration caused by polyQ expanded ataxin-7.
These findings could have implications in the development of therapies for
the treatment of SCA7.
S.K. Custer et al. (2006). Nat. Neurosci. 9, 1302–1311. Published online
August 27, 2006. 10.1038/nn1750.
Aprataxin Helps Mind the Gap
APTX is the gene responsible for the neurodegenerative disease ataxia oculomotor apraxia-1. Ahel et al. (2006) in-
vestigated whether APTX is involved in DNA repair given that aprataxin (the protein encoded by APTX) associates
with DNA repair proteins and APTX-defective cell lines are sensitive to DNA damage. DNA ligases are enzymes
responsible for repairing nicks in DNA. Certain DNA breaks, especially those caused by reactive oxygen species,
cause ‘‘abortive intermediates’’ where the 50 phosphate of the nicked DNA remains bound to adenosine monophos-
phate (AMP), which is normally an intermediate step in the ligation process. This AMP has to be removed for the
ligases to repair the nick. Is aprataxin the AMP-hydrolase that performs this reaction? The authors constructed
artificial substrates that mimicked an abortive intermediate and showed that wild-type aprataxin (from both human
and yeast), but not a version with a mutation in the predicted active site, can remove AMP. Extracts prepared from
primary cortical astrocytes from Aptx-deficient mice did not exhibit AMP-hydrolase activity. However, the addition
of purified aprataxin was sufficient to remove the abortive intermediates. Therefore, the molecular basis of ataxia
oculomotor apraxia-1 may be the accumulation of ligation intermediates and of unrepaired DNA strand breaks.
I. Ahel et al. (2006). Nature. Published online September 10, 2006. 10.1038/nature05164.
The Importance of Being Edited
A characteristic feature of many neurodegenerative diseases is the accumulation of misfolded proteins in specific
regions of the brain. Lee et al. (2006) set out to determine the genetic basis of themouse ‘‘sticky’’ (sti) mutation. These
mutant mice exhibit ataxia and neurodegeneration due to loss of cerebellar Purkinje cells. The authors mapped the
sti mutation to chromosome 8 and discovered a single nucleotide change in the sequence of the gene (Aars) that
encodes alanyl tRNA synthetase. tRNA synthetases are enzymes that attach the correct amino acid to a transfer-
RNA (tRNA). If the tRNA is charged with the incorrect amino acid—for example, the Ala tRNA synthetase can acci-
dentally charge tRNAAla with Glu or Ser instead of Ala—these enzymes have editing domains that recognize and
correct the mistake. The nucleotide change in Aars causes the mutation of an evolutionarily conserved amino
acid residue that is part of the predicted editing domain of this enzyme. The authors found that mouse embryonic
fibroblasts (MEFs) from sti mutant mice are less viable than their wild-type counterparts when grown in medium
enriched for serine. These mutant MEFs exhibit an increase in ubiquitinated proteins as well as the stress-induced
heat shock protein HSP72, both of which indicate the presence of misfolded proteins. The authors also showed that
the mutant mouse and human enzymes were defective in their ability to edit mischarged alanine tRNA. Examination
of the cerebellum of sti mice revealed the presence of structures that resembled protein inclusions, as well as an
increase in ubiquitinated proteins, chaperones, co-chaperones, and ER proteins associated with the unfolded
protein response. This study shows that a defect in editing tRNAs can cause an increase in the amount of misfolded
proteins. It will be interesting to determine if such a defect is involved in certain human neurodegenerative diseases.
J.W. Lee et al. (2006). Nature 443, 50–55. Published online August 13, 2006. 10.1038/nature05096.
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